
Athersys Investor Relations Material
Latest events

Investor Update
Athersys
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Athersys Inc
Access all reports
Athersys, Inc., through its subsidiary, Healios K.K., focuses on the research and development of MultiStem cell therapy to treat various diseases; and marketing and developing of MultiStem as an off-the-shelf cell therapy to treat acute myocardial infarction, acute respiratory distress syndrome, ischemic stroke, and traumatic brain injury. It also focuses on research and development activities for a range of therapeutic applications in other areas, including hematology, inflammatory bowel disease and other gastrointestinal disorders, liver disease and repair, anti-inflammation in support of wound healing applications, bone fracture repair, trauma/surgical care applications, oncology supportive care applications, diabetes mellitus, retinitis pigmentosa, and human immunodeficiency virus associated morbidities.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
ATHX
Country
🇺🇸 United States